News from the healthcare data industry
When Robert Califf became the new commissioner of the U.S. Food & Drug Administration, he did so with a plan to emphasize the use of real-world evidence (RWE) in Agency decisions. So, even though the FDA has been evaluating the use of RWE and issued draft guidance a few months ago, “There’s still…
Findings highlight the unmet medical need among cancer patients with BRAF Class II and Class III alterations who may not have access to approved targeted therapies SAN FRANCISCO and SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery…
Company expands its offerings with a mission to organize digital health products that enable patients and their providers to make objective, data-driven decisions about their healthcare March 07, 2022 07:00 AM Eastern Standard Time AUSTIN, Texas–(BUSINESS WIRE)–MDisrupt, a digital health intelligence company, today announced it has raised $6M in funding…
The new investment will accelerate Health Gorilla’s mission to connect everyone, everywhere, with actionable health data. Palo Alto, California, March 07, 2022 (GLOBE NEWSWIRE) — Health Gorilla, a leading Health Information Network and interoperability provider, today announces it has raised $50 million in series C funding, led by San Francisco-based SignalFire…
Background To assess the performance of various coding algorithms for identifying people with hepatitis B virus (HBV) and hepatitis C virus (HCV) using claims data according to different reference standards (RSs) and study periods (SPs). Methods A proportional random sampling of 10,000 patients aged ≥ 20 years in a health care system in…
New partnership allows for a 40,000+ patient dataset to unlock new insights into cancer treatments and outcomes.xCures and BioSpark are driving a fundamental shift in the quality, utility, and value of real-world evidence. The research and commercial insights from this data will be unparalleled”— Mika Newton – CEO xCuresOAKLAND, CA,…
SAN FRANCISCO, March 3, 2022 /PRNewswire/ — NephroSant™ a biotechnology company dedicated to accelerating the diagnosis of early kidney damage in native and transplanted kidneys, with a mission to significantly improve global kidney health, announced that the Journal of Clinical Medicine has published real-world data (RWD) that provides insight into how changes in allograft health…
Abstract The landscape for evidence generation in hematologic malignancies is rapidly evolving. While randomized controlled trials (RCTs) remain the gold standard in support of drug efficacy, approval and use, the supplemental use of real-world data (RWD), generated as part of routine healthcare delivery, and real-world evidence (RWE), the insights derived…
“Hotspot mapping” accelerates early-phase drug design CCDC, Exscientia, and Oxford University collaborate on an automated, quantitative method for informing the design of compound selectivity across protein families Cambridge Crystallographic Data Centre (CCDC), Cambridge, UK— 2 March 2022 — The amount of structural data on protein drug targets continues to grow. However,…
Posted 02 March 2022 | By Mary Ellen Schneider Pharmaceutical manufacturers and patient advocates want to see more details from the US Food and Drug Administration as it finalizes guidance on the use real-world data (RWD) from registries, as well as alignment with three other RWD guidance documents. The comments were…